We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

About Vademécum Roemmers

Medications marketed by Laboratorios Roemmers and OOSS coverage.

Important: To activate the application, you must be a user of INTRAMED www.intramed.net

"Vademécum Roemmers" contains updated prescription drugs and OTC information, marketed in Argentina by Laboratorios Roemmers S.A.I.C.F.

The application can access the list of products through its trade name or active ingredient that composes. Product description includes the discount has in the main social and Works Calling Argentina, as well as access to the product insert.

This material is intended solely for use by doctors. The "Vade Mecum Roemmers" application has been developed by Laboratorios Roemmers S.A.I.C.F. It is aimed at health professionals providing information on products Laboratories Roemmers S.A.I.C.F. Full prescribing information is available in the prospectus included in the app or on the website of www.roemmers.com.ar laboratory. Upon the occurrence of an adverse event involving a product of Laboratorios Roemmers S.A.I.C.F. , Please call the area "Information professionals and users" 0800-333-5658

What's New in the Latest Version 1.1.67

Last updated on Aug 5, 2024

Minor bug fixes and improvements. Install or update to the newest version to check it out!

Translation Loading...

Additional APP Information

Latest Version

Request Vademécum Roemmers Update 1.1.67

Uploaded by

Sam Restu Fajar

Requires Android

Android 5.0+

Show More

Vademécum Roemmers Screenshots

Languages
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.